Bonn-Weiss Group
Indian medical device supply company offering guaranteed, zero-stockout supply of high-frequency hospital consumables through Digital LTAs and its CoreLineOS platform.
Last updated September 26, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Bonn-Weiss Group (BWG) is an Indian medical device supply company that positions itself around a single promise: guaranteed supply with zero stockouts. Rather than operating as a conventional distributor that reacts to hospital purchase orders, BWG sells what it calls a Digital LTA — a long-term agreement under which a facility commits volume, locks a price for three years, and receives a 52-week delivery calendar generated the moment the agreement becomes active. The company describes this as a fix for three chronic failures in hospital procurement: reactive spot-buying, volatile pricing that makes budgets unpredictable, and stockouts that pause patient care. The commercial model is built on vendor-managed inventory (VMI). BWG holds stock near the customer's facility and replenishes it automatically, so the hospital does not manually reorder. Every shipment is quality-control vetted and accompanied by batch documentation and traceability records, making each unit audit-ready from dispatch to patient. The whole schedule is managed through CoreLineOS, BWG's platform that consolidates orders, shipments, contracts, and compliance into one dashboard and drives the 52-week forecasting and delivery calendar. BWG focuses on a deliberately narrow set of high-volume, high-frequency consumables that virtually every hospital uses daily. Its three flagship product lines are auto-disable syringes, blood collection tubes, and IV infusion sets. The auto-disable syringes are described as US FDA 510(k) cleared and CE and ISO certified, with BIS also cited for the syringe line; blood collection tubes are marketed around diagnostic accuracy, full batch traceability, and automatic QC records; IV infusion sets are positioned for surgery, ICU, and emergency care, where uninterrupted supply is non-negotiable. Each product ships against a schedule managed in CoreLineOS. Positioning-wise, BWG presents itself less as a product manufacturer and more as a supply-chain infrastructure provider for healthcare. Its language — "It's about supply that never lets a procedure wait," "Lock supply on every SKU" — targets hospital procurement and supply-chain leaders who are trying to move away from unpredictable spot markets. The company is identified in public data as an Indian medical device supply company. Beyond that, details such as founding year, founders, headquarters city, ownership structure, and listing status are not established in the available evidence and are therefore left unstated here.
History
Bonn-Weiss Group is an Indian medical device supply company. The available evidence does not establish a founding year, founders, or a detailed corporate chronology; what it does document is the company's operating model and product scope as presented on its own website. BWG built its proposition around a critique of conventional hospital procurement. In its framing, facilities typically order consumables only when stock runs low, buying at whatever the market charges — reactive spot-buying. That behavior produces volatile pricing, so budgets swing with the market and spend cannot be planned with confidence. Worst of all, when an item is not on the shelf, a procedure is delayed. BWG summarizes this as "three failures, one fix." The fix is the Digital LTA. A hospital chooses products, duration, and shipment frequency, and locks its price instantly. The moment the agreement is active, BWG generates a 52-week delivery calendar covering the full annual schedule. Pricing is fixed for the full term of the agreement, described as a three-year price lock. BWG then manages supply through vendor-managed inventory held near the facility, with automatic replenishment, so the customer does not manually reorder. Before each dispatch, every shipment undergoes a full quality-control check and receives batch documentation. The operational backbone is CoreLineOS, which BWG describes as one dashboard for the whole supply chain — orders, shipments, contracts, and compliance in one place — and as the platform behind the 52-week delivery calendar. Every product ships against a schedule managed in CoreLineOS. Product scope is intentionally narrow: three high-volume, high-frequency consumables that hospitals use daily. Auto-disable syringes are positioned as the backbone of clinical operations, from routine injections to IV drug delivery, supplied with pre-planned replenishment schedules and complete batch certification and QC documentation attached to every shipment; the company cites US FDA 510(k) clearance, CE, BIS, and ISO for this line. Blood collection tubes are framed around diagnostic accuracy, with full batch traceability, quality documentation, and QC records attached automatically, and with the VMI model ensuring they never run out and every unit is audit-ready from dispatch to patient. IV infusion sets are positioned for surgery, ICU, and emergency care as among the highest-frequency consumables in any hospital, delivered on pre-planned schedules with instant documentation access. Public data identifies Bonn-Weiss Group simply as an Indian medical device supply company. Details of ownership, leadership, financing, and corporate milestones are not available in the supplied evidence and are not asserted here.
Products and positioning
Guaranteed, zero-stockout supply of high-frequency hospital consumables via Digital LTAs, 3-year price locks, 52-week delivery calendars, and the CoreLineOS supply-chain platform.
Auto-Disable Syringes
High-frequency syringes for routine injections and IV drug delivery, supplied on Digital LTAs with pre-planned replenishment, complete batch certification, and QC documentation attached to every shipment. Cited certifications: US FDA 510(k), CE, BIS, ISO.
Blood Collection Tubes
Diagnostic consumables supplied with full batch traceability, quality documentation, and automatically attached QC records; the VMI model keeps them in stock and audit-ready from dispatch to patient.
IV Infusion Sets
Critical-care consumables for surgery, ICU, and emergency care, delivered on pre-planned schedules with instant documentation access and regulatory compliance.
CoreLineOS
BWG's supply-chain platform: one dashboard for orders, shipments, contracts, and compliance, and the system behind the 52-week delivery calendar and forecasting.
Digital LTA
A long-term agreement in which the customer chooses products, duration, and shipment frequency, locks price instantly for the full term (3-year price lock), and receives a 52-week delivery calendar at signing.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/bonn-weiss-group · Editorial policy · How profiles are compiled